Iiro Jokinen
About Iiro Jokinen
Iiro Jokinen is the Head of Service Development at Farenta in Espoo, Finland, with over 20 years of experience in the pharmaceutical industry, focusing on market access, health economics, and patient access.
Current Position at Farenta
Iiro Jokinen is currently the Head of Service Development at Farenta, based in Espoo, Uusimaa, Finland. In this role, he focuses on creating and developing innovative service solutions. His efforts have contributed to enhancing Farenta's service portfolio, making it more comprehensive and competitive in the market.
Role at Eli Lilly and Company
Iiro Jokinen worked at Eli Lilly and Company as the Pricing, Reimbursement, and Access And Corporate Affairs Director. During his 10-year tenure from 2008 to 2018 in Indianapolis, Indiana, United States, he played a key role in shaping pricing and reimbursement strategies. His contributions were significant to Eli Lilly's market success, ensuring the company's products met regulatory and market demands.
Career at Pfizer
Iiro Jokinen held numerous positions at Pfizer over a span of a decade. His roles included Nordic Health Economics Manager, Senior Manager of Patient Access, Senior Manager of Outcomes Research, Outcomes Research Manager, Business Development Manager, Marketing Planning Manager, and Sales Manager and Field Supervisor. These roles, based in New York, New York, United States, ranged from 1995 to 2008, focusing on health economics, patient access, and business development.
Market Access Manager at Bristol-Myers Squibb
Before joining Eli Lilly, Iiro Jokinen served as a Market Access Manager at Bristol-Myers Squibb in New Jersey, United States. His work in this role helped pave the way for his extensive experience in the pharmaceutical industry, focusing on market access and the economic assessment of healthcare interventions.
Experience in the Pharmaceutical Industry
With over 20 years of experience in the pharmaceutical industry, Iiro Jokinen has specialized in market access, health economics, and patient access. His expertise extends to the Nordic healthcare market, where he has focused on health economics and outcomes research. He also has a strong background in corporate affairs, managing complex stakeholder relationships and navigating regulatory challenges efficiently.